BioAge Labs Ownership | Who Owns BioAge Labs?
BioAge Labs Ownership Summary
BioAge Labs is owned by 28.11% institutional investors, 2.56% insiders, and 69.33% retail investors. Ah capital management is the largest institutional shareholder, holding 9.02% of BIOA shares.
BIOA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioAge Labs | 28.11% | 2.56% | 69.33% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ah capital management | 3.23M | 9.02% | $19.01M |
| Sofinnova investments | 2.29M | 6.40% | $13.49M |
| Cormorant asset management, lp | 2.14M | 5.97% | $12.59M |
| Adar1 capital management | 1.88M | 5.24% | $11.05M |
| Tang capital management | 1.60M | 4.46% | $9.41M |
| Blackrock funding, inc. /de | 1.53M | 4.26% | $20.21M |
| Vanguard group | 1.41M | 3.95% | $18.72M |
| Orbimed advisors | 790.90K | 2.21% | $4.65M |
| Sands capital ventures | 786.35K | 2.19% | $4.62M |
| Pivotal bioventure partners investment advisor | 653.37K | 1.82% | $3.84M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 653.37K | 2.22% | $3.84M |
| Ah capital management | 3.23M | 1.36% | $19.01M |
| Redpoint management | 383.25K | 1.36% | $2.25M |
| Adar1 capital management | 1.88M | 1.04% | $11.05M |
| Sands capital ventures | 786.35K | 1.01% | $4.62M |
| Nano cap new millennium growth fund l p | 80.00K | 0.90% | $1.06B |
| Stonepine capital management | 188.57K | 0.90% | $1.11M |
| Cormorant asset management, lp | 2.14M | 0.87% | $12.59M |
| Sofinnova investments | 2.29M | 0.74% | $13.49M |
| Tang capital management | 1.60M | 0.36% | $9.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acadian asset management | 277.96K | 0.01% | 267.28K |
| Blackrock funding, inc. /de | 1.53M | 0.00% | 247.92K |
| Bnp paribas arbitrage, snc | 111.79K | 0.00% | 86.05K |
| Morgan stanley | 311.66K | 0.00% | 83.50K |
| Nano cap new millennium growth fund l p | 80.00K | 0.90% | 80.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | - | - | -1.45M |
| Ra capital management | - | - | -1.05M |
| Rtw investments, lp | - | - | -786.35K |
| Siren | - | - | -382.41K |
| Vanguard group | 1.41M | 0.00% | -236.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nano cap new millennium growth fund l p | 80.00K | 0.90% | 80.00K | $1.06B |
| Occudo quantitative strategies lp | 19.30K | 0.01% | 19.30K | $113.45K |
| Fox run management | 18.03K | 0.04% | 18.03K | $238.59K |
| Great lakes advisors | 16.20K | 0.00% | 16.20K | $214.31K |
| Metlife investment management | 14.44K | 0.00% | 14.44K | $191.00K |
Sold Out
| Holder | Change |
|---|---|
| Mendota financial group | -10.00 |
| Clearstead advisors | -18.00 |
| Principal securities | -41.00 |
| Federated hermes | -184.00 |
| Svb wealth | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 65 | -31.58% | 10,078,271 | -52.59% | 28 | 0.80% | 41 | -6.82% | 11 | -47.62% |
| Sep 30, 2025 | 92 | 10.84% | 21,046,072 | 1.59% | 58 | 1.76% | 42 | -23.64% | 20 | 122.22% |
| Jun 30, 2025 | 83 | 27.69% | 20,716,579 | 2.74% | 57 | 1.83% | 55 | 77.42% | 9 | -50.00% |
| Mar 31, 2025 | 65 | 6.56% | 20,244,679 | 3.38% | 56 | 1.37% | 30 | -31.82% | 18 | 80.00% |
| Dec 31, 2024 | 63 | 10.53% | 19,640,328 | -4.98% | 64 | 1.40% | 46 | -19.30% | 10 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 02, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $139.37K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $40.54K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $165.37K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $86.37K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell | $239.55K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
BIOA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools